Seller record · Telehealth service

AbundRX

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The home page refers to a licensed pharmacy, and the terms to a preferred pharmacy and participating pharmacies. 1 more criterion also fails; see the table below.

At a glance

AbundRXTelehealth service

6/8criteria passed

Price: Semaglutide from $99, tirzepatide from $149
Sells: compounded semaglutide, compounded tirzepatide
FDA letters: None on file

Visit AbundRX See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Florida-based telehealth service selling compounded semaglutide and tirzepatide care plans with provider review and follow-up. Care starts with an online health intake, and the pharmacy is not named.

Operating entity Abundant Wellness Corp

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	AbundRX's website; AbundRX's shippingpolicy page
S2	Prescription gating	PASS	AbundRX's website; AbundRX's shippingpolicy page
S3	Pharmacy identification	FAIL	AbundRX's website; AbundRX's terms
S4	Compounding disclosure	PASS	AbundRX's website
S5	Analytical documentation	FAIL	AbundRX's website; AbundRX's terms; AbundRX's refund page
S6	Business address	PASS	AbundRX's contact page; AbundRX's refund page; AbundRX's terms
S7	Price disclosure	PASS	AbundRX's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews each intake and prescribes only after that review, and the home page names three of the providers.Source: AbundRX's website; AbundRX's shippingpolicy page.

S2PASSThe home page says care begins with a brief health intake that a licensed provider reviews, and the shipping policy says an order goes to the pharmacy only after the provider approves a prescription; no page describes payment before the intake.Source: AbundRX's website; AbundRX's shippingpolicy page.

S3FAILNo filling pharmacy is named. The home page refers to a licensed pharmacy, and the terms to a preferred pharmacy and participating pharmacies.Source: AbundRX's website; AbundRX's terms.

S4PASSThe home page states beneath the two treatment options, and again in its answers, that compounded medications are not FDA-approved.Source: AbundRX's website.

S5FAILNo certificate of analysis or lot document is published on the home page, the terms, the refund policy or the shipping policy.Source: AbundRX's website; AbundRX's terms; AbundRX's refund page.

S6PASSAbundant Wellness Corp at 3200 Summit Blvd, PO Box 17686, West Palm Beach, FL 33416, a post office box, printed on the contact page, in the footer and as the returns address in the refund policy. The terms name Georgia law, with arbitration in Miami under Florida law.Source: AbundRX's contact page; AbundRX's refund page; AbundRX's terms.

S7PASSA semaglutide care option from $99 and a tirzepatide care option from $149, with no period stated beside either. A banner offers premium access for $99 with free shipping.Source: AbundRX's website.

S8PASSNo FDA warning letter names AbundRX or Abundant Wellness Corp, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit AbundRX

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.